Sectors
ENLV
Enlivex Therapeutics Ltd.
4.66
1 x 4.70
3 x 5.05
bid
ask
-
0.07
1.48%
10:02 AM
timesize
| Ytd | -55.83% | |
| 1y | -73.67% |
4.57
day range
4.80
4.25
52 week range
31.50
| Open | 4.65 | Prev Close | 4.73 | Low | 4.57 | High | 4.80 | Mkt Cap | 79.62M |
| Vol | 6.47K | Avg Vol | 38.19K | EPS | 404.50 | P/E | 0.01 | Forward P/E | -2.14 |
| Beta | 1.52 | Short Ratio | 0.56 | Inst. Own | 18.81% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-30 | 50-d Avg | 9.36 | 200-d Avg | 13.56 | 1yr Est | 9.50 |
| Income Statement | |||
| Operating Expenses | 5.86M | ||
| Research and Development Expense | 3.03M | ||
| Selling, General and Administrative Expense | 2.83M | ||
| Operating Income | -5.86M | ||
| Interest Expense | 1.64M | ||
| Income Tax Expense | 382.65M | ||
| Net Income | 1.24B | ||
| Net Income Common Stock | 1.24B | ||
| Net Income Common Stock (USD) | 1.24B | ||
| Consolidated Income | 1.24B | ||
| Earnings per Basic Share | 410.65 | ||
| Earnings per Basic Share (USD) | 410.65 | ||
| Earnings per Diluted Share | 386.65 | ||
| Earning Before Interest & Taxes (EBIT) | 1.63B | ||
| Earning Before Interest & Taxes (USD) | 1.63B | ||
| Weighted Average Shares | 3.05M | ||
| Weighted Average Shares Diluted | 3.23M | ||
| Balance Sheet | |||
| Cash and Equivalents | 5.76M | ||
| Cash and Equivalents (USD) | 5.76M | ||
| Investments | 2.32B | ||
| Investments Current | 1.73B | ||
| Investments Non-Current | 582.51M | ||
| Current Assets | 1.74B | ||
| Property, Plant & Equipment Net | 361.00K | ||
| Total Assets | 2.33B | ||
| Total Debt | 383.00K | ||
| Current Liabilities | 9.02M | ||
| Debt Non-Current | 383.00K | ||
| Total Liabilities | 392.05M | ||
| Accumulated Retained Earnings (Deficit) | 1.11B | ||
| Accumulated Other Comprehensive Income | 1.10M | ||
| Shareholders Equity | 1.93B | ||
| Shareholders Equity (USD) | 1.93B | ||
| Assets Non-Current | 583.82M | ||
| Total Debt (USD) | 383.00K | ||
| Liabilities Non-Current | 383.03M | ||
| Trade and Non-Trade Payables | 3.81M | ||
| Tax Liabilities | 382.65M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 76.00K | ||
| Net Cash Flow from Financing | 9.83M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.17M | ||
| Capital Expenditure | -910.00K | ||
| Issuance (Purchase) of Equity Shares | 9.83M | ||
| Net Cash Flow from Investing | -9.38M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -9.84M | ||
| Net Cash Flow from Operations | -2.63M | ||
| Share Based Compensation | 915.00K | ||